Publicaciones (55) Publicaciones en las que ha participado algún/a investigador/a

2024

  1. A quantitative weight-of-evidence method for confidence assessment of adverse outcome pathway networks: A case study on chemical-induced liver steatosis

    Toxicology, Vol. 505

  2. Anti-miR-873-5p improves alcohol-related liver disease by enhancing hepatic deacetylation via SIRT1

    JHEP Reports, Vol. 6, Núm. 1

  3. Assessing ATR-FTIR spectroscopy for steatosis quantification in liver biopsies in a long-duration cross-sectional study

    Microchemical Journal, Vol. 198

  4. Cluster-Partial Least Squares (c-PLS) regression analysis: Application to miRNA and metabolomic data

    Analytica chimica acta, Vol. 1286, pp. 342052

  5. Exploring Individual Variability in Drug-Induced Liver Injury (DILI) Responses through Metabolomic Analysis

    International Journal of Molecular Sciences, Vol. 25, Núm. 5

  6. Novel clinical phenotypes, drug categorization, and outcome prediction in drug-induced cholestasis: Analysis of a database of 432 patients developed by literature review and machine learning support

    Biomedicine and Pharmacotherapy, Vol. 174

  7. Progress and challenges of mid-infrared spectroscopy for liver characterization focusing on steatosis, fibrosis and cancer

    Applied Spectroscopy Reviews, Vol. 59, Núm. 4, pp. 578-599

  8. Protectiveness of NAM-based hazard assessment - which testing scope is required?

    ALTEX, Vol. 41, Núm. 2, pp. 302-319

  9. Report of the First ONTOX Stakeholder Network Meeting: Digging Under the Surface of ONTOX Together With the Stakeholders

    Alternatives to Laboratory Animals, Vol. 52, Núm. 2, pp. 117-131

  10. Uncovering the toxicity mechanisms of a series of carboxylic acids in liver cells through computational and experimental approaches

    Toxicology, Vol. 504

2023

  1. A robust reprogramming strategy for generating hepatocyte-like cells usable in pharmaco-toxicological studies

    Stem Cell Research and Therapy, Vol. 14, Núm. 1

  2. Analysis of longitudinal metabolomic data using multivariate curve resolution-alternating least squares and pathway analysis

    Chemometrics and Intelligent Laboratory Systems, Vol. 232

  3. Automated Generation of hiPSC-Derived Hepatic Progeny by Cost-Efficient Compounds

    Stem cells (Dayton, Ohio), Vol. 41, Núm. 11, pp. 1076-1088

  4. Comparing the direct assessment of steatosis in liver explants with mid- and near-infrared vibrational spectroscopy, prior to organ transplantation

    The Analyst, Vol. 148, Núm. 17, pp. 3986-3991

  5. Enhancing the accuracy of mid-infrared spectroscopy-based liver steatosis quantification using digital image analysis as a reference

    Analyst, Vol. 148, Núm. 13, pp. 3097-3106

  6. Gut Microbiota and Plasma Bile Acids Associated with Non-Alcoholic Fatty Liver Disease Resolution in Bariatric Surgery Patients

    Nutrients, Vol. 15, Núm. 14

  7. Mechanistic Understanding of Idiosyncratic Drug-Induced Hepatotoxicity Using Co-Cultures of Hepatocytes and Macrophages

    Antioxidants, Vol. 12, Núm. 7

  8. Metabolomic Diversity of Human Milk Cells over the Course of Lactation—A Preliminary Study

    Nutrients, Vol. 15, Núm. 5

  9. Metabolomics-based strategy to assess drug hepatotoxicity and uncover the mechanisms of hepatotoxicity involved

    Archives of Toxicology, Vol. 97, Núm. 6, pp. 1723-1738

  10. Optimization of an adverse outcome pathway network on chemical-induced cholestasis using an artificial intelligence-assisted data collection and confidence level quantification approach

    Journal of biomedical informatics, Vol. 145, pp. 104465